FDA Inspection
Berkshire Sterile Manufacturing, LLCBerkshire Sterile Manufacturing, LLC – FDA Inspection, Jun 12, 2024
Record Details
This FDA Inspection record concerns Berkshire Sterile Manufacturing, LLC, with an inspection on June 12, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 9be0692d-4278-4a48-acf6-6a063244f8c2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1240940
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.42(c)(3)Released Material Area
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Berkshire Sterile Manufacturing, LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2026 | Not classified | New England District Office | Drug Quality Assurance |
| October 21, 2024 | Not classified | New England District Office | |
| August 25, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 15, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Berkshire Sterile Manufacturing, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.